Ecstasy for PTSD? LSD and Psilocybin Mushrooms for cluster headaches? Put on the shelf for decades there is currently a resurgence of studies being conducted utilizing illegal substances. Gaining momentum, as well as positive reviews in popular media outlets, our students are hearing about such research. Psychedelic research was prominent in the 1950s and 60s, but was quickly put on the shelf for approximately 35 years for various social, political, and health reasons. Recently there has been a surge in psychedelic research, and it isn't underground. Recently, Sanjay Gupta (CNN) ran a short story on the research being conducted using MDMA (ecstasy) in a therapeutic setting for individuals with PTSD. Oprah Magazine featured a similar article earlier this year, and both were favorable in nature. Additionally, we are seeing research utilizing substances such as LSD, Psilocybin Mushrooms, Marijuana, and Ibogaine. Because this information is being shared publicly through informal means, and in media outlets, it is an important topic for practitioners to have awareness of. Will this research impact on perception of harm? Will it eventually lead to the re-scheduling of certain drugs from Schedule 1 to Schedule 2? If so, what with the impacts be on availability and use? Some of the research is being conducted at prestigious universities such as Johns Hopkins Medical School, Harvard, and UCLA School of Medicine. What influence do the research institutions play in the perceived outcomes? We will explore these and other questions in the session.